This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Panacea Biotec Limited. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: **Sastry V R S Thungathurthi: Innovator in SGLT Inhibitors**
Introduction
Sastry V R S Thungathurthi, an esteemed inventor based in New Delhi, India, has made significant contributions to the field of pharmaceutical innovation. With a patent to his name, he exemplifies the spirit of invention through his groundbreaking work on SGLT inhibitors, which hold promise in treating various medical conditions.
Latest Patents
Thungathurthi's notable patent focuses on the development of novel compounds represented by Formula I. The invention encompasses their pharmaceutically acceptable derivatives, tautomeric forms, isomers, polymorphs, prodrugs, metabolites, salts, or solvates. This patent also covers the synthesis processes for these compounds and offers pharmaceutical compositions that incorporate these innovative molecules. In addition, his work aims to address diseases that can be regulated through the inhibition of Sodium Glucose Cotransporter-2 (SGLT-2), indicating its potential in metabolic and cardiovascular health.
Career Highlights
Currently, Sastry V R S Thungathurthi is associated with Panacea Biotec Limited, a prominent pharmaceutical company known for its dedication to research and innovation in drug development. His contributions within the organization have helped advance the treatment landscape for various conditions, showcasing his expertise and commitment to improving patient health outcomes.
Collaborations
Throughout his career, Thungathurthi has collaborated with notable colleagues, including Rajesh Jain and Sanjay Trehan. These partnerships have facilitated a synergistic approach to research and development, enriching the inventive processes and fostering advancements in pharmaceutical science.
Conclusion
In conclusion, Sastry V R S Thungathurthi stands as a distinguished figure in the pharmaceutical industry, contributing to the advancement of innovative solutions in healthcare through his patent on SGLT inhibitors. His work exemplifies the crucial role of inventors in shaping the future of medicine and improving the quality of life for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile